Pub. L. 117-328, div. FF, tit. III, subtit. A, sec. 3101

REAUTHORIZATION OF THE CRITICAL PATH PUBLIC-PRIVATE PARTNERSHIP.

EnactedYear: 2022Length: 52 wordsOfficial source
SEC. 3101. REAUTHORIZATION OF THE CRITICAL PATH PUBLIC-PRIVATE PARTNERSHIP. Section 566(f) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360bbb–5(f)) is amended by striking “$1,265,753 for the period beginning on October 1, 2022 and ending on December 23, 2022” and inserting “$6,000,000 for each of fiscal years 2023 through 2027”.
Pub. L. 117-328, div. FF, tit. III, subtit. A, sec. 3101: REAUTHORIZATION OF THE CRITICAL PATH PUBLIC-PRIVATE PARTNERSHIP. | Justis AI